(Non-targeted) radioactive/fluorescent nanoparticles and their potential in combined pre- and intraoperative imaging during sentinel lymph node resection.
One clinical precedent for the use of nanosized imaging agents is the localization of the tumor draining sentinel lymph nodes. In this application, radiocolloids such as (99m)Tc-NanoColl are currently used to plan the surgical procedure and to provide acoustic guidance during the intervention. Additional injections of dyes are common to provide optical surgical guidance. Bimodal imaging agents, which are both radioactive and fluorescent, have the potential to be used for both surgical planning and intraoperative fluorescence guidance towards the sentinel lymph nodes. This review provides an overview of the radioactive, fluorescent, and size properties of (non-targeted) bimodal nanoparticles, and their (potential) value in sentinel lymph node detection.
Department of Radiology, Division of Diagnostic Oncology at the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Tessa
T
Buckle
Patrick T K
PT
Chin
Fijs W B
FW
van Leeuwen
D000818:Animals; D003952:Diagnostic Imaging / Q000379:methods*; D005453:Fluorescence; D006801:Humans; D007430:Intraoperative Care / Q000379:methods*; D053758:Nanoparticles; D011300:Preoperative Care / Q000379:methods*; D011868:Radioisotopes; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*
D011868:Radioisotopes